| Prev Close | 224.81 |
| Day Low/High | 222.25 / 226.62 |
| 52 Wk Low/High | 166.68 / 244.99 |
| Avg Volume | 3.44M |
Amgen Inc. (AMGN)
225.09
0.28
0.12
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 588.25M |
| Market Cap | 130.83B |
| EPS | 13.00 |
| P/E Ratio | 17.60 |
| Div & Yield | 6.40 (2.68%) |
This 2019 Market Optimism Is Misplaced: Market Recon
Take upbeat outlooks for equities with a grain of salt, and try these sectors to stay safe.
The Real Money Post-Industrial Average Has Jumped 11% So Far This Year
For the month of November RMPIA climbed 1.2% month over month.
Pfizer Shares Jump on Monday After Company Signals Higher Price Push
Pfizer pushes higher on price increases.
Tech Selloff Could Work in Favor of Pharmaceutical Stocks
Pharma could be the best parking spot for your money if the market keeps trending downward.
Amgen Is Showing Independent Strength in a Bullish Sign for the Future
Investors should continue to hold Amgen.
Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken
Once the safest stocks in the book, the big-cap drug companies are now toxic.
Staying Long Apple Into Tuesday's Product Launch: Market Recon
My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.
Here Are 9 Takeaways From Last Night's Meltdown: Market Recon
It becomes difficult for me to tell you where to run in these markets...
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Novice Trade: Amgen
Amgen calls just look too cheap to pass up here.
Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop
It is all about perception, and here are strong names to pick up on market weakness.
Biotechs: Adding to Radius Health, Flexion
This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.
3 Best Ways to Play Amazon, Starbucks and Amgen After Earnings
Here are 3 ways to play these 3 stocks on earnings.
Charting 3 Big Names After Earnings
How to play Amazon, Starbucks and Amgen on earnings news.
Biotech Stocks Rally on Biogen's Landmark Test
Investors might be finally recognizing the hidden value of the firms' drug research and development.
Amgen Is Ready to Breakout on the Upside
Let's go to the charts.
Jim Cramer: Move Over FANG, Long Live INJFANG
The Nasdaq hit an all-time high today, and It's Not Just FANG anymore.
Emboldened By Biotech Names
For the trade, I'm opting to use the iShares Nasdaq Biotechnology ETF.
When the Stock Is the Only Option
Options spreads aren't tradable with some small biotechs, making shares the only way to play.
Jim Cramer: Are Markets Getting Tired of Trump, Trade and Tariffs?
Sooner or later, bargain hunters will say: 'Enough already. It can't be that bad.'
Feels Like the Semis Are Skating on Thin Ice: Market Recon
Forward looking valuations, except for Nvidia, are very low.
Here's My Take on Biotech Stocks
I think M&A activity will pick up markedly going forward across the industry.
These 2 Widely Held Stocks Look Good Short
Our 'bearish bets' show weak technical characteristics and have received recent quant downgrades.
Cramer vs. Chaikin: Amgen -- Be Careful of This Stock
TheStreet's Jim Cramer and Marc Chaikin, of Chaikin Analytics, spent an hour together at our offices talking all things markets. Listen to the whole conversation below. In the except above, they discuss Amgen and why Chaikin says to be careful of the stock.
The Shifting Price Action Continued Today
The good news is that volatility is increasing. The bad news, for some, is that it moves in both directions.
The Really Big Money Rushes to Super Bowl
This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.
Cramer: Step Away and Get Your Clients Better Prices
You mean to tell me if the buyers walked away for 10 minutes they couldn't get these stocks lower?
Jim Cramer: Stocks Are on Fire For Good Reasons
Stocks put in broad gains supported by tax cuts, bonuses, a weaker dollar and more.
3 More Stocks To Buy on Tax Reform
Rent-A-Center, Foot Locker and AV Homes will get a nice holiday gift with the tax deal.
7 Hot Investing Bets to Make in Biotech
These favorite names in the volatile sector offer the potential for high rewards.
